Author | Tracey Walker

Articles

FDA approves luliconazole for tinea pedis

November 18, 2013

The Food and Drug Administration has approved luliconazole (Luzu Cream, 1 percent, Valeant Pharmaceuticals) for the two-week, once-daily treatment of interdigital tinea pedis, tinea cruris, and tinea corporis, caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients ages 18 and older.